: Taxonomic profiles of the 84 analyzed 16S rRNA profiling datasets. The bar plot 2 shows taxonomy profiles at genera level of taxa with relative abundance >1 %. AB-, AB+ 3 and CDI datasets are grouped separately. (CDI: Clostridium difficile infected samples; AB+: 4 Clostridium difficile-negative samples, patients exposed to antibiotic treatment; AB-: 5 Clostridium difficile-negative samples, patients not exposed to antibiotic treatment). 6 7 Figure S2. Functional changes in the gut microbiome of AB+ and CDI compared to AB-8 subjects, part 1. Panel a shows relative abundance of Clostridium difficile microbial 9 biomarkers (CDImb) in AB-, AB+ and CDI shotgun metagenomic datasets. Panel b reports 10 the relative abundance of taxa with supposed health-promoting activities and opportunistic 11 pathogens in AB-, AB+ and CDI samples. Panel c illustrates percentage variation in 12 abundance of enzymes and transporters involved in antibiotic resistance in AB+ and CDI 13 compared to AB-subjects as well as CDI compared to AB+ subjects. Panel d depicts 14 variations of abundance of Cluster of Orthologous Genes (COG) functional families involved 15 in energy production in AB+ and CDI compared to AB-samples. COG functional families 16 are abbreviated as follows: [C] Energy production and conversion, [G] Carbohydrate 17 transport and metabolism, [E] Amino acid transport and metabolism. Panel e shows changes 18 in Glycosyl Hydrolase (GH) families involved in glucose (circled in green) and fructose 19 (circled in purple) production in AB+ and CDI compared to AB-datasets. Panel f exhibits 20 variation in bile salts and bile acid degradation pathways in AB+ and CDI compared to AB-21 samples as well as CDI compared to AB+ subjects. Panel g displays variation of pathways 22 involved in butyrate production in AB+ and CDI compared to AB-samples as well as CDI 23 compared to AB+ subjects. Panel h shows variation of pathways involved in succinate 24 production in AB+ and CDI compared to AB-samples as well as CDI compared to AB+ 25
subjects. (CDI: Clostridium difficile infected samples; AB+: Clostridium difficile-negative 1 samples, patients exposed to antibiotic treatment; AB-: Clostridium difficile-negative 2 samples, patients not exposed to antibiotic treatment). the commensals/(opportunistic) pathogens ratio observed for the Peptostreptococcaceae 10 family population in AB-, AB+ and CDI datasets. (CDI: Clostridium difficile infected 11 samples; AB+: Clostridium difficile-negative samples, patients exposed to antibiotic 12 treatment; AB-: Clostridium difficile-negative samples, patients not exposed to antibiotic 14AB+  192800  68806  0  12214  1236  11039  26415  73090  167.6  15AB+  155536  45816  0  40475  141  7015  32043  30046  163.5  16AB+  121227  52190  0  7261  1190  3747  14700  42139  165.3  17AB+  162464  65499  0  11420  337  11104  19654  54450  169.7  18AB+  148437  46913  0  8493  405  10080  22871  59675 
